The Latest Breaking News from FDA

The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To capitalize on the industry’s expansion, it could be wise to invest in fundamentally sound biotech stocks, Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), and Biogen (BIIB), which have the potential to revolutionize medicine. Read…

Hot food preparation was shut down following an inspection

A new FDA rule requires that screenings inform people if they have a high ratio of dense breast tissue. Experts say it’s just one step toward awareness

This top-rated healthcare stock is poised for substantial growth after securing FDA approval for its innovative non-invasive cancer diagnostic.

How the FDA and DEA overrule the interests of doctors and patients.

Travere Therapeutics stock popped Wednesday after a group of experts suggested an alternative means of measuring the success of FSGS drugs.

A top U.S. commercial bakery is pushing back on a Food and Drug Administration warning to stop using labels that say its products contain sesame — even when they don't

McKinsey & Company and other consulting firms have long faced criticisms for their involvement with governments. Investigative journalists and academics alike have flagged their growing influence, citing cases like the staggering expenses of up to £1 million per day on private consultants for the UK’s Covid-19 Test-and-Trace service, or the…

Not only are microplastics essentially unavoidable, but the alleged harm they pose has been wildly overblown.